Top Story

Radiofrequency ablation safe, effective for medically inoperable NSCLC

July 2, 2015

Radiofrequency ablation conferred 2-year OS rates comparable to stereotactic body radiotherapy in patients with medically inoperable non–small cell lung cancer, according to study results.

Further, radiofrequency ablation appeared safe and did not adversely affect pulmonary function tests, the study also found.

Meeting News Coverage

Clinical trials, health information technology platform to test power of precision medicine

July 2, 2015
CHICAGO — Precision medicine represents a potentially practice-changing advance in the landscape of cancer treatment. Yet, the ability to gather and analyze data…
Drug Pipeline

New collaboration looks to bring potential liver cancer, melanoma drug to China

July 2, 2015
Provectus Biopharmaceuticals, Inc. announced it has signed a Letter of Intent with Boehringer Ingelheim Investment Co. Ltd. in China to collaborate in marketing its…
Ran Reshef, MD In the Journals

Higher CD8 T-cell dose from younger donors improves allogeneic HSCT outcomes

July 2, 2015
A higher graft CD8 dose from younger donors — even if they are not related to the patient — predicted improved survival in patients with hematologic…
In the Journals

Clonal hematopoiesis common, variable in patients with aplastic anemia

July 2, 2015
Clonal hematopoiesis commonly occurs in patients with aplastic anemia, according to study results. Although detected somatic mutations were associated with clinical…
More News Headlines »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

June 19, 2015
CHICAGO — Vernon K. Sondak, MD, chair of the department of cutaneous oncology at Moffitt Cancer Center and a…
More »
Tailored Therapies for Myelodysplastic Syndromes

Tailored Therapies for Myelodysplastic Syndromes

This activity is supported by an educational grant from Celgene Corporation.

Myelodysplastic syndromes (MDS) represent a group of myeloid clonal hemopathies with heterogeneous clinical…
More »
morganatic-roan
morganatic-roan